Frederick’s RoosterBio Releases RoosterGEM™, Cell and Gene Therapy’s First Complete Transduction Medium

Published on :

RoosterBio Inc., a leading supplier of human mesenchymal stem/stromal cell (hMSC) working cell banks and hMSC bioprocess systems for cell and gene therapy product developers, today announced the launch of its product RoosterGEM™, a stand-alone, complete gene transfer medium that is optimized to remove key challenges in primary cell genetic modification. RoosterGEM, abbreviated for Rooster Genetic Engineering Medium, complements RoosterBio’s hMSC cell engineering system to offer a new and streamlined path for discovery, preclinical, and applied product development research – faster than ever before.

RoosterBio Partners with Sartorius to Advance Cell and Gene Therapy Manufacturing

Published on :

FREDERICK, Md., Jan. 14, 2021 (GLOBE NEWSWIRE) — RoosterBio Inc., a leading supplier of human mesenchymal stem/stromal cell (hMSC) working cell banks, highly engineered media and hMSC bioprocess systems, today announces the signing of a strategic collaboration with Sartorius, a leading international partner of life science research and the biopharmaceutical industry. The collaboration aims to…

5 Questions with Ben Woodard, Business Development Partner, ABIO

Published on :

Ben Woodard is a Business Development Partner with ABIO and a recent retiree of the University of Maryland, where he was the Executive Director of the Biotech Research Program (BREP) for over a decade.

5 Questions with Mark Nardone, PMP, Director, Bio-Trac®

Published on :

Mark Nardone is Director and Co-Founder of Bio-Trac®, a biotechnology training program that has served the scientific community for over 37 years, providing hands-on training workshops, designed by active researchers for research scientists, that focus on the latest relevant techniques that are necessary for laboratory research.

5 Questions with Ian Sarad, BioProcess Application Engineer, Scientific Bioprocessing

Published on :

Ian is an industrial microbiologist and fermentation scientist specializing in process optimization and upstream modification of cell culture parameters for increased yield, viability, and productivity. Experienced with a variety of fermentation technologies, including hollow-fiber bioreactor systems, industrial stirred-tanks, and shake-flasks, Ian is excited to lend his background in cell culture to the SBI team.

5 Questions with Mike O’Mara, VP of Industrial Business Services, Miltenyi Biotec

Published on :

Mike O’Mara has more than 27 years of experience in biopharmaceutical contract manufacturing encompassing microbial, mammalian, and cell/Gene therapy manufacturing processes ranging from Preclinical/Phase I through Commercial.